Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Dermatologic 1

Conditions

Prostatic Neoplasms 1Precancerous Conditions 1Pancreatic Neoplasms 1Lymphoma, Follicular 1Keratosis, Actinic 1Breast Neoplasms 1

Interventions

Cyclophosphamide 7fludarabine phosphate 6Peripheral Blood Stem Cell Transplantation 6Whole-Body Irradiation 5Tacrolimus 4Mycophenolic Acid 4Melphalan 4Busulfan 4Sulindac 3Methotrexate 3Biopsy 3Antilymphocyte Serum 3fludarabine 2Sirolimus 2Patient Reported Outcome Measures 2Mesna 2Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2Gene Expression Profiling 2Etoposide 2Epoetin Alfa 2Eflornithine 2Cyclosporine 2Cetuximab 2Celecoxib 2vandetanib 1tanespimycin 1sintilimab 1perillyl alcohol 1antitumor A 1aldesleukin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Precancerous Conditions × perillyl alcohol × Clear all
NCT00608634 2015-04-01

Topical Perillyl Alcohol in Treating Patients With Sun Damaged Skin and Actinic Keratoses

University of Arizona

Phase 2 Completed
89 enrolled 10 charts
DermatologicOther neoplasm

Precancerous Conditions, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡